To include your compound in the COVID-19 Resource Center, submit it here.

FeRx begins three MTC-DOX trials

FeRx (San Diego, Calif.) started an international Phase II/III trial in 240

Read the full 120 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE